Minimizing Disability: An Overview of the Pervasiveness,Clinical Manifestations and Treatment of Depression in Parkinson's Disease

Abstract

This review was conducted to establish the degree to which depression can intensify and further complicate the difficulty of living with Parkinson's disease. The authors evaluated the literature on depression in Parkinson's disease, to better understand and report on its pervasiveness, clinical manifestations, and treatment. As a result of an extensive literature review, the analysis focused on Parkinson's disease depression research that has been conducted by the medical, social work, and psychological communities. The results suggest that nearly one third of all Parkinson's patients had some form of depression over the course of their disease. The clinical manifestations of Parkinson's disease depression are daunting including yet not limited to feelings of helplessness and hopelessness, psychomotor retardation, memory impairment, irrational thought processes, and suicidal ideation. Parkinson's disease depression can be successfully treated with a multiplicity of antidepressants. Selective serotonin reuptake inhibitors such as citalopram, escitalopram, fluoxetine, paroxetine, or sertraline are the most effective in treating depression, and hence the most commonly prescribed.

Keywords

Parkinson's disease depression antidepressants

Get full access to this article

View all access options for this article.

References

Coffey CE , Cummings JL Parkinson's disease and parkinsonism. In: Textbook of Geriatric Neuropsychiatry. Washington, DC: American Psychiatric Press; 1994: 434-456.

Hubble JP , Koller WC The parkinsonian personality. Adv Neurol. 1995;65:43-48.

Sano M. , Stern Y. , Williams J. , et al. Coexisting dementia and depression in Parkinson's disease. Arch Neurol. 1989;46:1284-1286.

Mayeux R. , Stern Y. , Rosen J. , et al. Depression intellectual impairment, and Parkinson disease. Neurology. 1981;31:645-650.

Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR 4th ed. Text Revised). American Psychiatric Association Press; Washington, DC; 2000.

Brown RG , MacCarthy B. , Jahanshahi M. , et al. Accuracy of self-reported disability in patients with parkinsonism . Arch Neurol. 1989;46:955-959.

Taylor A. , Saint-Cyr JA , Lang AE , et al. Parkinson's disease and depression: a critical re-evaluation . Brain. 1986;109:279-292.

Huber SJ , Paulson GW , Shuttleworth EC Depression in Parkinson's disease. Neuropsychiatry. Neuropsychol Behav Neurol. 1988;1:47-51.

Rondot P. , de Recondo J. , Coignet A. , et al. Mental disorders in Parkinson's disease after treatment with L-dopa. Adv Neurol. 1984;40:259-269.

10.

Gotham AM , Brown RG , Marsden CD Depression in Parkinson's disease: a quantitative and qualitative analysis . J Neurol Neurosurg Psychiatry. 1986;49: 381-389.

11.

Oyebode JR , Barker WA , Blessed G. , et al. Cognitive functioning in Parkinson's disease: in relation to prevalence of dementia and psychiatric diagnosis. Br J Psychiatry . 1986;149:720-725.

12.

Mindham RHS , Marsden CD , Parkes JD Psychiatric symptoms during L-dopa therapy for Parkinson's disease and their relationship to physical disability. Psychol Med. 1976;6:23-33.

13.

Rogers D. , Lees AJ , Smith E. , et al. Bradyphrenia in Parkinson's disease psychomotor retardation in depressive illness: an experimental study. Brain. 1987;110:761-776.